Changes in the haemocoagulation system after pregravid preparation before ART programme in pregnant women with a history of sexually transmitted infections

Authors

DOI:

https://doi.org/10.15574/HW.2023.164.28

Keywords:

sexually transmitted infections, pregravid preparation, pregnancy, haemoaculatory homeostasis

Abstract

Purpose - to analyze the dynamics of laboratory parameters of haemocoagulation system functioning after pregravid preparation before assisted reproductive technologies (ART) cycles in pregnant women with a history of sexually transmitted infections (STIs).

Materials and methods. The functioning of the haemocoagulation system after the ART program in women with infertility and a history of STIs was analyzed: the Group 1 - 56 pregnant women received the treatment and preventive measures proposed by us in the pregravid period; the Group 2 - 55 pregnant women received conventional treatment and preventive measures. The state of the hemostasis system was assessed by the following indicators: fibrinogen concentration, activated recalcification time, activated partial thromboplastin time (APTT), integrative «index of thrombodynamic potential» (ITP), concentration of fibrin and fibrinogen degradation products (FDP) and the level of more stable but less biologically active metabolites of prostacyclin (6-keto-PGF1α) and thromboxane (T×B2). The statistical processing of the study results was performed using standard software «Microsoft Excel 5.0» and «Statistica 8.0».

Results. During the period of final formation of the placental barrier in pregnant women of the Group 1, the APTT slowly lengthened (31.3±1.6 s - in the trimester ІІ; 34.3±2.9 s - in the trimester III) with increasing gestational age and significantly differed from the indicators in the Group 2 (27.6±3.0 s and 30.2±1.7 s, respectively; p<0.05); activated recalcification time slowly decreased during the trimesters II and III of gestation in pregnant women of the Group 1 (63.1±2.8 s and 59.3±2.8 s, respectively); gradually decreased the level of FDP (5.8±0.27×10-2 g/l and 5.1±0.22×10-2 g/l), in contrast to the level of FDP in the Group 2, in which this indicator gradually increased (9.4±0.17×10-2 g/l and 11.6±0.27×10-2 g/l); (p<0.01). The level of stable T×B2 in the trimester II decreased by 2 times and was lower (p<0.05) than in the Group 2; the level of stable 6-keto-PGF1α increased in the trimester III (p<0.05). This resulted in an increase in the PgI2/T×A2 balance in the Group 1 from 0.34±0.02 to 1.16±0.03, which corresponded to the physiological needs of systemic and organ hemodynamics during pregnancy.

Conclusions. The development and implementation of effective pregravid preparation before ART cycles in women with a history of STIs and medical correction during pregnancy contribute to the increase of the adaptive compensatory and adaptive potential of maternal haemocoagulation homeostasis and perinatal fetal care.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the authors.

References

Bitsadze V, Khizroeva J, Elalamy I, Makatsariya A. (2020, Oct 26). Venous thrombosis risk factors in pregnant women. J Perinat Med: jpm-2020-0011. Online ahead of print. https://doi.org/10.1515/jpm-2020-0011; PMid:33098632

Brenner B. (2004). Haemostatic changes in pregnancy. Thromb Res. 114 (5-6): 409-414. https://doi.org/10.1016/j.thromres.2004.08.004; PMid:15507271

Chen L, Liu J, Cao Z. (2019). Seasonal influence on TORCH infection and analysis of multi‐positive samples with indirect immunofluorescence assay. J Clin Lab Anal. 33 (4): e22828. URL: https:/www.ncbi.nlm.nih.gov/pmc/articles/. (Accessed 11 March 2021). https://doi.org/10.1002/jcla.22828; PMid:30666721 PMCid:PMC6528586

Curry K et al. (2022). Recommendations for managing sexually transmitted infections: Incorporating the 2021 guidelines. The Nurse Practitioner. 47 (4): 10-18. https://doi.org/10.1097/01.NPR.0000822528.27483.b2; PMid:35349512

Erez O. (2017, Mar). Disseminated intravascular coagulation in pregnancy - Clinical phenotypes and diagnostic scores. Thrombosis research. 151 (1): S56-S60. https://doi.org/10.1016/S0049-3848(17)30069-5; PMid:28262236

Evarista OO, Ezimokhai TP, Airiagbonbu B. (2020). Effect of highly active antiretroviral therapy (HAART) on some specific clotting profile in Human Immunodeficiency Virus-(HIV) positive pregnant women. Indian Journal of Sexually Transmitted Diseases and AIDS. 41 (1): 83. https://doi.org/10.4103/ijstd.IJSTD_107_17; PMid:33062988 PMCid:PMC7529161

Holovachuk OK, Kalinovska IV. (2014). Klinichna otsinka platsentarnoyi dysfunktsiyi u vahitnykh iz henitalnymy infektsiyamy. Perinatologiya i pediatriya. 4: 31-33. https://doi.org/10.15574/PP.2014.60.31

Kolomiytseva AH, Didenko LV, Chernenko TS. (2008). Prohnozuvannya i profilaktyka uskladnen vahitnosti. Pediatriya, akusherstvo ta hinekol. 1: 52-53.

Krotik OI. (2022). Obstetric and perinatal outcomes of childbirth after ART in women with a history of sexually transmitted infections. Ukrainian Journal Health of Woman. 1 (158): 25-33. https://doi.org/10.15574/HW.2022.158.25

Lowe GDO, Rumley A. (2019). Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events. Thrombosis and Haemostasis J. 82; 2: 667-673. https://doi.org/10.1055/s-0037-1615895; PMid:10605766

Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 8: 112-118.

Rabinovich A et al. (2019, Sep). DIC in obstetrics: Diagnostic score, highlights in management, and international registry‐communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 17 (9): 1562-1566. https://doi.org/10.1111/jth.14523; PMid:31218838

Şahin B, Şahin B, Şahin GC. (2022). Sexually Transmitted Infections in Pregnancy, Screening and Treatment. Current Obstetrics and Gynecology Reports. 11: 34-43. https://doi.org/10.1007/s13669-021-00318-z

Schjetlein R, Haugen G, Wisloff F. (1997). Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstetricia et Gynecologica Scandinavica. 76; 6: 541-546. https://doi.org/10.3109/00016349709024580; PMid:9246959

Xiao J, Feng Y, Li X et al. (2017). Expression of ADAMTS13 in normal and abnormal placentae and its potential role in angiogenesis and placenta development. Arterioscler Thromb Vasc Biol. 37 (9): 1748-1756. https://doi.org/10.1161/ATVBAHA.117.309735; PMid:28751574 PMCid:PMC5570641

Published

2023-03-15